STERIS Operating Margin 2010-2022 | STE

Current and historical operating margin for STERIS (STE) over the last 10 years. The current operating profit margin for STERIS as of September 30, 2022 is 16.94%.
STERIS Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-09-30 $4.78B $0.15B 3.08%
2022-06-30 $4.77B $0.57B 11.94%
2022-03-31 $4.59B $0.43B 9.29%
2021-12-31 $4.25B $0.48B 11.25%
2021-09-30 $3.85B $0.42B 10.97%
2021-06-30 $3.41B $0.45B 13.09%
2021-03-31 $3.11B $0.55B 17.63%
2020-12-31 $3.06B $0.56B 18.38%
2020-09-30 $3.02B $0.56B 18.43%
2020-06-30 $3.00B $0.54B 18.08%
2020-03-31 $3.03B $0.54B 17.72%
2019-12-31 $2.98B $0.52B 17.44%
2019-09-30 $2.90B $0.45B 15.42%
2019-06-30 $2.84B $0.43B 15.04%
2019-03-31 $2.78B $0.41B 14.77%
2018-12-31 $2.73B $0.38B 14.07%
2018-09-30 $2.70B $0.42B 15.47%
2018-06-30 $2.65B $0.41B 15.43%
2018-03-31 $2.62B $0.40B 15.27%
2017-12-31 $2.59B $0.34B 13.31%
2017-09-30 $2.57B $0.27B 10.39%
2017-06-30 $2.58B $0.24B 9.22%
2017-03-31 $2.61B $0.23B 8.69%
2016-12-31 $2.62B $0.27B 10.26%
2016-09-30 $2.59B $0.29B 11.18%
2016-06-30 $2.44B $0.24B 9.97%
2016-03-31 $2.24B $0.21B 9.51%
2015-12-31 $2.05B $0.18B 8.87%
2015-09-30 $1.91B $0.20B 10.29%
2015-06-30 $1.88B $0.23B 12.03%
2015-03-31 $1.85B $0.23B 12.21%
2014-12-31 $1.81B $0.22B 12.02%
2014-09-30 $1.75B $0.21B 12.19%
2014-06-30 $1.67B $0.21B 12.59%
2014-03-31 $1.62B $0.21B 12.75%
2013-12-31 $1.59B $0.21B 13.37%
2013-09-30 $1.56B $0.22B 14.29%
2013-06-30 $1.53B $0.24B 15.34%
2013-03-31 $1.50B $0.24B 16.12%
2012-12-31 $1.46B $0.25B 17.16%
2012-09-30 $1.44B $0.24B 16.55%
2012-06-30 $1.43B $0.22B 15.72%
2012-03-31 $1.41B $0.22B 15.85%
2011-12-31 $1.40B $0.21B 14.77%
2011-09-30 $1.37B $0.19B 13.74%
2011-06-30 $1.34B $0.20B 14.58%
2011-03-31 $1.21B $0.09B 7.04%
2010-12-31 $1.16B $0.08B 6.89%
2010-09-30 $1.16B $0.10B 8.87%
2010-06-30 $1.16B $0.10B 8.43%
2010-03-31 $1.26B $0.20B 16.22%
2009-12-31 $1.27B $0.20B 15.75%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $18.026B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.198B 22.61
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00